Tirzepatide
A dual GIP/GLP-1 receptor agonist reported for even more significant weight loss than Semaglutide.
People use this for
Benefit Profile
Tirzepatide's fingerprint across categories
Community Interest
Report volume over 12 months
Reported Benefits
1 of 1Dramatic Weight Loss
Strongly Positive"Lost 60 lbs in 5 months. More effective than Semaglutide for me with fewer sides."
Unexpected Findings
Interesting effects reported by users
Similar to Semaglutide, users report reduced compulsive shopping, gambling, and other impulsive behaviors.
“The compulsive Amazon shopping stopped too. Walked past a sale and felt nothing. That has never happened.”
Reported Side Effects
Common during dose titration.
Some GI disturbance reported.
Dosing Patterns
Most Popular: SubQ at 2.5-15 mg
95% of community members report using this dosing protocol 1x weekly. Individual responses vary — start low and adjust based on your experience.
Where to Buy
Trusted vendors recommended by the community. We may receive a commission from purchases.
Peptide Sciences
USA-based, 3rd party tested, COA provided
Swiss Chems
European quality standards, bulk discounts
Amino Asylum
Competitive pricing, fast US shipping
Limitless Life
Premium quality, pharmaceutical grade
Disclaimer: DYK Peptides may receive affiliate commissions from purchases made through these links. This does not affect our editorial integrity or the recommendations we provide. Peptides are sold for research purposes only and are not intended for human consumption. Always consult with a healthcare professional before using any research compounds.
Commonly Stacked With
Frequently Asked
Tirzepatide activates both GIP and GLP-1 receptors, potentially providing greater weight loss efficacy.